港股異動 | 盛業資本(6069.HK)逆勢大漲超7% 獲納入恆生綜合指數
格隆匯2月24日丨盛業資本(6069.HK)今日逆勢走強,現大漲7.36%,報7港元,暫成交13542港元,最新總市值61.7億港元。恆生指數公司21日晚間宣佈截至2019年12月31日恆生指數系列季度檢討結果,有關變動將於2020年3月9日(星期⼀)起生效。其中,盛業資本(6069.HK)獲納入恆生綜合指數。市場人士指出,公司獲納入恆生綜合指數,反映出資本市場對公司業務及經營的高度肯定,有助於擴大公司的股東基礎及提高公司在資本市場知名度。作為國內首家在香港聯交所上市的商業保理公司,盛業資本同時也具備稀缺性價值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.